journal article·2015-01-27Open access

pH-Controlled Gas-Generating Mineralized Nanoparticles: A Theranostic Agent for Ultrasound Imaging and Therapy of Cancers

Kyung Hyun Min, Hyun Su Min, Hong Jae Lee, Dong Jin Park, Ji Young Yhee, Kwangmeyung Kim, Ick Chan Kwon, Seo Young Jeong, Oscar F. Silvestre, Xiaoyuan Chen, Yu-Shik Hwang, Eun-Cheol Kim, Sang Cheon Lee

ACS Nano· Volume 9· Issue 1

Abstract

We report a theranostic nanoparticle that can express ultrasound (US) imaging and simultaneous therapeutic functions for cancer treatment. We developed doxorubicin-loaded calcium carbonate (CaCO3) hybrid nanoparticles (DOX-CaCO3-MNPs) through a block copolymer templated in situ mineralization approach. The nanoparticles exhibited strong echogenic signals at tumoral acid pH by producing carbon dioxide (CO2) bubbles and showed excellent echo persistence. In vivo results demonstrated that the DOX-CaCO3-MNPs generated CO2 bubbles at tumor tissues sufficient for echogenic reflectivity under a US field. In contrast, the DOX-CaCO3-MNPs located in the liver or tumor-free subcutaneous area did not generate the CO2 bubbles necessary for US contrast. The DOX-CaCO3-MNPs could also trigger the DOX release simultaneously with CO2 bubble generation at the acidic tumoral environment. The DOX-CaCO3-MNPs displayed effective antitumor therapeutic activity in tumor-bearing mice. The concept described in this work may serve as a useful guide for development of various theranostic nanoparticles for US imaging and therapy of various cancers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Photoacoustic and Ultrasonic Imaging · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 136-791, Republic of Korea

Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, Maryland 20892, United States

Department of Maxillofacial Biomedical Engineering & Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul 130-701, Republic of Korea

Department of Life and Nanopharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 130-701, Republic of Korea

Department of Maxillofacial Tissue Regeneration and Research Center for Tooth and Periodontal Regeneration (MRC), School of Dentistry, Kyung Hee University, Seoul 130-701, Republic of Korea

Funding

National Research Foundation of Korea

References (43)

Show source-provided references
1. Lindner J. R. · Nat. Rev. Drug Discovery · 2004 · 3 · 52710.1038/nrd1417 ↗
2. Stewart V. R. · Br. J. Radiol. · 2006 · 79 · 18810.1259/bjr/17790547 ↗
3. Willmann J. K. · Nat. Rev. Drug Discovery · 2008 · 7 · 59110.1038/nrd2290 ↗
4. Qin S. P. · Phys. Med. Biol. · 2009 · 54 · R2710.1088/0031-9155/54/6/R01 ↗
5. Ferrara K. · Annu. Rev. Biomed. Eng. · 2007 · 9 · 41510.1146/annurev.bioeng.8.061505.095852 ↗
6. Schutt E. G. · Angew. Chem., Int. Ed. · 2003 · 42 · 321810.1002/anie.200200550 ↗
7. Kiessling F. · Theranostics · 2011 · 1 · 12710.7150/thno/v01p0127 ↗
8. Hernot S. · Adv. Drug Delivery Rev. · 2008 · 60 · 115310.1016/j.addr.2008.03.005 ↗
9. Sanna V. · Mol. Pharmaceutics · 2011 · 8 · 74810.1021/mp100360g ↗
10. Willmann J. K. · J. Nucl. Med. · 2010 · 51 · 43310.2967/jnumed.109.068007 ↗
11. Iagaru A. · Am. J. Roentgenol. · 2013 · 201 · W18310.2214/AJR.12.8568 ↗
12. Wilson S. R. · Radiology · 2010 · 257 · 2410.1148/radiol.10091210 ↗
13. Willmann J. K. · Radiology · 2008 · 246 · 50810.1148/radiol.2462070536 ↗
14. Kiessling F. · Theranostics · 2011 · 1 · 12710.7150/thno/v01p0127 ↗
15. Bloch S. H. · Appl. Phys. Lett. · 2004 · 84 · 63110.1063/1.1643544 ↗
16. Min H. S. · Biomaterials · 2012 · 33 · 93610.1016/j.biomaterials.2011.09.082 ↗
17. Kang E. · Angew. Chem., Int. Ed. · 2010 · 49 · 52410.1002/anie.200903841 ↗
18. Janib S. M. · Adv. Drug Delivery Rev. · 2010 · 62 · 105210.1016/j.addr.2010.08.004 ↗
19. Tassa C. · Acc. Chem. Res. · 2011 · 44 · 84210.1021/ar200084x ↗
20. Ambrogio M. W. · Acc. Chem. Res. · 2011 · 44 · 90310.1021/ar200018x ↗
21. Melancon M. P. · Acc. Chem. Res. · 2011 · 44 · 94710.1021/ar200022e ↗
22. Pan D. · J. Am. Chem. Soc. · 2008 · 130 · 918610.1021/ja801482d ↗
23. Taratula O. · Mol. Pharmaceutics · 2013 · 10 · 394610.1021/mp400397t ↗
24. Xiao Y. · Theranostics · 2012 · 2 · 75710.7150/thno.4756 ↗
25. Yoo D. · Acc. Chem. Res. · 2011 · 44 · 86310.1021/ar200085c ↗
26. Kim D. · ACS Nano · 2010 · 4 · 368910.1021/nn901877h ↗
27. Choi K. Y. · Biomaterials · 2012 · 33 · 618610.1016/j.biomaterials.2012.05.029 ↗
28. Gerweck L. E. · Cancer Res. · 1996 · 56 · 1194
29. Min K. H. · J. Controlled Release · 2010 · 144 · 25910.1016/j.jconrel.2010.02.024 ↗
30. Lee H. J. · Chem. Commun. · 2010 · 46 · 37710.1039/B913732G ↗
31. Min K. H. · Biomaterials · 2012 · 33 · 578810.1016/j.biomaterials.2012.04.057 ↗
32. Rim H. P. · Angew. Chem., Int. Ed. · 2011 · 50 · 885310.1002/anie.201101536 ↗
33. Choi B. · Int. J. Pharm. · 2002 · 239 · 8110.1016/S0378-5173(02)00054-6 ↗
34. Naka K. · Langmuir · 2002 · 18 · 365510.1021/la011345d ↗
35. Goss S. L. · J. Pharm. Pharmacol. · 2007 · 59 · 148510.1211/jpp.59.11.0004 ↗
36. Wike-Hooley J. L. · Radiother. Oncol. · 1984 · 2 · 34310.1016/S0167-8140(84)80077-8 ↗
37. Nido P. J. D. · Am. J. Physiol. · 1998 · 274 · 728
38. Fonteriz R. I. · Cell Calcium · 2010 · 48 · 6110.1016/j.ceca.2010.07.001 ↗
39. Daly W. H. · Tetrahedron Lett. · 1988 · 29 · 585910.1016/S0040-4039(00)82209-1 ↗
40. Lee S. J. · Biomacromolecules · 2011 · 12 · 122410.1021/bm101517x ↗
41. Harada A. · Macromolecules · 1998 · 31 · 28810.1021/ma971277v ↗
42. Decano J. L. · Mol. Imaging Biol. · 2011 · 13 · 109610.1007/s11307-010-0444-4 ↗
43. Min K. H. · J. Controlled Release · 2008 · 127 · 20810.1016/j.jconrel.2008.01.013 ↗